Hepatocellular carcinoma tissue microarray, 3 cores per case. Pathology grade, TNM Classification and Clinical stage information available. Replacing BS03013.
- 20 cases of liver hepatocellular carcinoma
- 3 cases of cancer adjacent tissue
Price
$170.00
Catalogue No | DLV03013a |
Species | Human |
Fixative | Formalin |
Total Cases | 23 |
Total Cores | 63 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LI | LI | LI | LI | LI | LI | LI | LI | LI |
B | LI | LI | LI | LI | LI | LI | LI | LI | LI |
C | LI | LI | LI | LI | LI | LI | LI | LI | LI |
D | LI | LI | LI | LI | LI | LI | LI | LI | LI |
E | LI | LI | LI | LI | LI | LI | LI | LI | LI |
F | LI | LI | LI | LI | LI | LI | LI | LI | LI |
G | LI | LI | LI | LI | LI | LI | LI | LI | LI |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
2 | A2 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
3 | A3 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
4 | A4 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant |
5 | A5 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant |
6 | A6 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant |
7 | A7 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
8 | A8 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
9 | A9 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
10 | B1 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
11 | B2 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
12 | B3 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant |
13 | B4 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant |
14 | B5 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant |
15 | B6 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant |
16 | B7 | 50 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant |
17 | B8 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
18 | B9 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
19 | C1 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
20 | C2 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
21 | C3 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
22 | C4 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
23 | C5 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
24 | C6 | 35 | M | Liver | Hepatocellular carcinoma (sparse) | 2 | T3N0M0 | IIIA | Malignant |
25 | C7 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
26 | C8 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
27 | C9 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
28 | D1 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
29 | D2 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
30 | D3 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
31 | D4 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T3N1M0 | IIIC | Malignant |
32 | D5 | 52 | M | Liver | Hepatocellular carcinoma with necrosis | 2 | T3N1M0 | IIIC | Malignant |
33 | D6 | 52 | M | Liver | Hepatocellular carcinoma with necrosis | 2 | T3N1M0 | IIIC | Malignant |
34 | D7 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
35 | D8 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
36 | D9 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
37 | E1 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
38 | E2 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
39 | E3 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
40 | E4 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
41 | E5 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
42 | E6 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
43 | E7 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
44 | E8 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
45 | E9 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
46 | F1 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
47 | F2 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
48 | F3 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
49 | F4 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
50 | F5 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
51 | F6 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
52 | F7 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
53 | F8 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
54 | F9 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
55 | G1 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
56 | G2 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
57 | G3 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
58 | G4 | 57 | M | Liver | Hepatocellular carcinoma | 3 | T2N0M0 | II | Malignant |
59 | G5 | 57 | M | Liver | Hepatocellular carcinoma | 3 | T2N0M0 | II | Malignant |
60 | G6 | 57 | M | Liver | Hepatocellular carcinoma (sparse) | 3 | T2N0M0 | II | Malignant |
61 | G7 | 60 | M | Liver | Cancer adjacent normal liver tissue | - | - | - | NAT |
62 | G8 | 70 | M | Liver | Cancer adjacent normal liver tissue | - | - | - | NAT |
63 | G9 | 54 | F | Liver | Chronic hepatitis | - | - | - | Inflammation |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |